{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihzekxwoof3geeevbhglka3z64jtgf5gm7l7n5z54fmxe4l74xegu",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mgnmajaoor22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicvnzhmb5xzowh7v5xstpqvsyi6uzfgrfbz6uk3licyzz6ebbhjaa"
    },
    "mimeType": "image/webp",
    "size": 54064
  },
  "path": "/releases/2026/03/260307213232.htm",
  "publishedAt": "2026-03-08T06:26:37.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of psilocybin from “magic mushrooms” — that still target key serotonin pathways linked to depression and other brain disorders but appear to cause far fewer psychedelic-like effects.",
  "title": "A new “magic mushroom” drug could treat depression without psychedelic hallucinations"
}